$LRCXBullishMed

Why Lam Research (LRCX) Stock Is Trading Up Today

Lam Research shares rose 2.8% in the morning after UBS raised its price target to $375 from $310, according to UBS. The upgrade follows Lam’s strong fiscal Q3 results in April, when it beat revenue and EPS estimates, and reflects improving semiconductor demand tied to AI and higher wafer-fab equipment spending expectations. After the initial jump, shares traded around $324.65.

7/10
4/10
Med
Bullish
morning session after UBS raised its price target
Risk-on for semicap equipment; analyst target increase aligns with improving AI/wafer-fab spending expectations

UBS’s price-target hike is the immediate catalyst supporting near-term upside momentum in LRCX, reinforcing the AI/wafer-fab capex demand narrative.

Lam Research shares jumped 2.8% after UBS raised its price target to $375 from $310, citing momentum from strong fiscal Q3 results.

Bullish bias for the session and potentially into the next few days as traders react to the fresh analyst target change; follow-through depends on whether broader semicap sentiment holds.

Background

Lam Research reported strong fiscal third-quarter results in April, exceeding revenue and EPS estimates; today’s rally builds on that momentum.

Why it matters

UBS’s raised target provides a fresh, attributable catalyst for traders, while the broader driver remains AI-driven semiconductor demand and expectations for higher wafer-fab equipment spending.

Market relevance

A same-day analyst price-target increase is driving a near-term momentum trade in LRCX, with the fundamental backdrop already set by prior earnings strength and AI/wafer-fab capex expectations.

Market effects

Reinforces positive read-through for semiconductor equipment demand tied to AI and wafer-fab capex expectations.

Primarily US semicap sentiment; no specific regional macro driver cited.

Supports the broader global semiconductor equipment complex via AI-related capex optimism.

Alternative perspectives

The article frames the move as meaningful but not perception-changing; if the stock is already near 52-week highs, upside may fade without new guidance or order data.

Analyst target hikes can be partially reflexive; traders may discount it if subsequent checks (bookings, lead times, or competitor commentary) don’t confirm accelerating wafer-fab equipment spending.

Key entities

  • Lam Research

    Semiconductor equipment maker whose shares rose after UBS raised its price target.

  • UBS

    Raised its LRCX price target to $375 from $310, cited as the reason for today’s jump.

  • Nvidia CEO Jensen Huang

    Commented that the prior selloff was a chance to buy at a discount, supporting sector sentiment.

Related articles

$LRCXMed

Why Is Lam Research Stock Soaring Thursday? - Lam Research (NASDAQ:LRCX)

Lam Research (LRCX) shares rose about 6-7% on Thursday amid a broader technology rally and a push into semiconductor equipment stocks. Mizuho kept an Outperform rating and raised its forecast to $400 from $380, and TD Cowen raised its Buy target to $400 from $340. The article cites July 29 earnings expectations of $1.68 EPS on $6.66B revenue.

$LRCXMed

Why is Lam Research stock surging today? By Investing.com

Lam Research (LRCX) shares rose about 7.8% in pre-open trading as semiconductors rebounded after two sessions of losses. The move followed easing “sell-the-news” pressure after Samsung’s preliminary record Q2 operating profit and reports of strong AI memory demand. Analysts at TD Cowen, Mizuho, Morgan Stanley and Susquehanna raised LRCX price targets to $400-$475.

$MUMed

Chip stocks sell off after Samsung earnings fall short of high AI bar

Semiconductor stocks fell after Samsung Electronics’ quarterly results missed high AI-related expectations, with shares down ~8%. Samsung reported profit above Nvidia and Apple and guided operating profit up $1,800%. SK Hynix, U.S. memory makers (Micron, Sandisk), major chip firms, and the iShares Semiconductor ETF declined, with investors also watching SK Hynix’s Nasdaq listing.

$CRNXMed

Stocks making the biggest moves premarket: Fiserv, Crinetics Pharmaceuticals, Micron & more

Premarket movers: Fiserv rose >5% after WSJ sources said it discussed selling its debit-card payments infrastructure to banks including JPMorgan and Bank of America. Vertex will buy Crinetics in a $10B deal; Crinetics shares roughly doubled. First Solar gained ~3% on a Deutsche Bank upgrade. Micron fell ~5% on Samsung-led AI-chip sentiment; Rivian fell ~9% after guidance beat but a 75M-share raise. Kospi slid >4%; EWY down ~4.6%.

$INTCMed

Stocks making the biggest moves premarket: Lam Research, Intel, Datadog & more

Premarket movers included SOXX up 2.5% after a prior 11% two-day drop. Intel rose ~2.5%, AMD ~3%, Broadcom ~2%. ASML gained ~4% after Bernstein raised its price target to $2,300. Comcast rose 0.5% on Sky’s plan to buy ITV’s TV business. T-Mobile climbed after BofA upgraded; Datadog fell after Bernstein downgraded; Lam Research, Applied Materials, and KLA jumped on Morgan Stanley target hikes.

$MUMed

Micron Technology Has Fantastic News for This Artificial Intelligence (AI) Infrastructure Stock That Has More Than Doubled in 2026

Micron Technology (MU) reported fiscal Q3 ended May 28 with revenue up 346% YoY to $41.5B and EPS up 1,215%, citing DRAM and NAND demand exceeding industry supply. Micron said tight supply should persist beyond 2027 and forecast $27B capex for fiscal 2026 and $10B for the current quarter. Lam Research (LRCX) rose after Micron results; it sells memory manufacturing equipment and expects higher revenue amid capex spending.